Riskpilot← Back to searchSign inGet full accessDR. ESBEN STORVAND AS
ASActiveOrg 989723839Søsterhjemmet Medisinske Senter Gamlevegen 19, 3922 PorsgrunnGeneral medical practice activities · NACE 8621Est. 20063 employees
Revenue 2024
NOK 4,8M
+4% vs 2023
EBITDA margin
36.9%
+3% vs 2023
Equity ratio
95.5%
Financial strength
Net profit 2024
NOK 3,3M
+13% vs 2023
| Revenue | NOK 4,8M | +4% |
| EBITDA | NOK 1,8M | +3% |
| Net profit | NOK 3,3M | +13% |
| Total assets | NOK 14,8M | +25% |
| Equity | NOK 14,1M | +31% |
| Employees | 3 | — |
Legal name
DR. ESBEN STORVAND AS
Org number
989723839
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
24. april 2006
Share capital
NOK 30 000
Employees
3 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Legevirksomhet, eie aksjer i andre selskaper samt finansiering og annen økonomisk virksomhet som står i forbindelse med dette.
Address
Søsterhjemmet Medisinske Senter Gamlevegen 19, 3922 Porsgrunn
Phone
+4735564800
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 011 | 4 098 | 4 203 | 4 609 | 4 799 |
| Staff expenses | −1 324 | −1 312 | −1 448 | −1 457 | −1 469 |
| EBITDA | 1 523 | 1 260 | 1 449 | 1 715 | 1 771 |
| Depreciation & amort. | −27 | −23 | −12 | −17 | −11 |
| EBIT | 1 496 | 1 237 | 1 438 | 1 699 | 1 760 |
| Net financials | 448 | 2 658 | 203 | 1 605 | 1 973 |
| Profit before tax | 1 944 | 3 896 | 1 641 | 3 304 | 3 733 |
| Tax | 331 | 291 | 314 | 356 | 388 |
| Net profit | 1 613 | 3 605 | 1 327 | 2 948 | 3 344 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 209 | 7 911 | 10 296 | 11 883 | 14 805 |
| Equity | 1 911 | 5 516 | 9 043 | 10 791 | 14 135 |
| Long-term debt | 1 681 | 1 324 | 468 | 0 | 0 |
| Short-term debt | 617 | 1 071 | 785 | 1 092 | 670 |
| Total debt | 2 298 | 2 395 | 1 253 | 1 092 | 670 |
EBITDA margin
36.9%
This company
15.8%
Market median
+134% vs market
20202024
Equity ratio
95.5%
This company
38.2%
Market median
+150% vs market
20202024
Return on equity
23.7%
This company
18.4%
Market median
+29% vs market
20202024
Net profit margin
69.7%
This company
8.1%
Market median
+760% vs market
20202024
Asset turnover
0.32×
This company
1.12×
Market median
-71% vs market
20202024
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EJ Deputy Member | Deputy Member | 2007 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2007 | |
| Board of Directors | 2007 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
DR. ESBEN STORVAND AS 
VAKSINE24 ASBoard members of DR. ESBEN STORVAND AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Emma Jane Storvand | Deputy Member | 0 companies |
| Esben Storvand | Chairman | 0 companies |
| Jonas Øyvind Christensen | Board of Directors | 0 companies |